Jubilant Ingrevia Peer Comparison

NSE: JUBLINGREA | BSE: 543271

₹632.35

₹26.35 (4.35%)

As on 27-Oct-2026IST

Market cap

₹10,041 Cr

Revenue (TTM)

₹4,924 Cr

P/E Ratio

28.6

P/B Ratio

3.1

Div. Yield

0.8 %

Edit

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Market cap (₹ Cr)	10,041	16,643	2,264	700	543
Revenue (₹ Cr)	4,924	2,384	2,661	265	370
Net Profit (₹ Cr)	350.69	426.07	150.91	29.95	34.14
Net Margin (%)	7.07	17.31	5.62	10.70	9.14
RoE (%)	11.17	15.32	11.15	6.23	16.17
Price to Earnings	28.64	39.06	14.82	23.38	15.86
Price-To-Book	3.13	5.73	1.61	1.47	2.51

Income Statement (₹ Cr)

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Operating Revenue	4,388.07	2,120.11	2,396.37	239.98	326.15
Total Income	4,428.60	2,184.95	2,435.59	255.43	334.48
Total Expenditure	3,821.03	1,685.40	2,127.31	209.81	283.04
EBITDA	567.04	434.71	269.06	30.17	43.11
Depreciation	175.49	45.13	79.12	11.55	5.35
EBIT	391.55	389.58	189.93	18.62	37.76
Interest	49.13	8.20	28.54	2.11	0.83
Other Income	40.53	64.84	39.23	15.45	8.33
Exceptional Items	-13.04	--	--	--	--
Profit before Tax	369.74	446.22	202.52	31.96	45.26
Provision for Tax	91.84	107.99	53.30	8.36	10.48
Profit after Tax	277.90	338.23	149.21	23.60	34.78

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Shareholder's Funds	3,126.22	2,656.16	1,333.35	483.14	206.99
Minority Interest	--	--	--	--	0.44
Non-Current Liabilities	751.59	61.69	314.55	6.33	1.92
Current Liabilities	1,591.71	292.39	1,006.67	78.49	42.42
Total Liabilities	5,469.52	3,010.24	2,654.57	567.96	252.19

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Non-Current Assets	3,423.15	1,714.18	1,193.78	221.96	35.28
Current Assets	2,046.37	1,295.48	1,453.02	346.01	216.48
Total Assets	5,469.52	3,010.24	2,654.57	567.96	252.19
Total Debt*	780.99	0.00	407.99	53.14	0.00
Net Current Assets	454.66	1,003.09	446.34	267.52	174.06
Contingent Liabilities	462.63	150.14	--	3.08	0.54

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Cash From Operating Activities	524.27	275.33	65.07	41.55	8.29
Cash Flow from Investing Activities	-275.93	-208.16	-219.48	-35.29	0.75
Cash from Financing Activities	-155.46	-59.55	186.32	-2.99	-4.04
Net Cash Inflow / Outflow	92.88	7.62	31.91	3.26	5.00

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
ROCE (%)	11.04	18.08	14.84	6.42	24.18
ROE (%)	9.25	13.45	11.88	4.80	18.92
ROA (%)	5.30	11.88	6.16	4.21	14.95
EBIT Margin (%)	13.85	23.56	12.86	19.01	15.77
Net Margin (%)	6.28	15.48	6.13	9.24	10.40
Cash Profit Margin (%)	10.32	17.98	9.49	14.65	12.31

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Revenue Growth (%)	5.04	0.51	15.19	15.71	11.59
EBIT Growth (%)	9.10	0.82	14.56	-3.24	7.55
Net Profit Growth (%)	10.64	2.12	9.41	-3.49	12.49
EPS Growth (%)	10.92	2.12	9.37	-3.49	--
Book Value Growth (%)	6.59	11.99	12.22	-3.50	28.75

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Price / Earnings	30.85	23.24	14.04	19.57	8.14
Price / Book Value	2.76	2.96	1.58	0.96	1.38
Dividend Yield (%)	0.92	0.35	0.13	5.15	1.18
EV/EBITDA	15.09	15.42	7.82	7.15	4.83
Market Cap (₹ Cr)	8,574.28	7,859.25	2,095.14	461.91	284.70

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Debt to Equity	0.25	0.00	0.31	0.11	0.00
Short term debt to equity ratio	0.11	--	0.21	0.11	--
Current Ratio	1.29	4.43	1.44	4.41	5.10
Quick Ratio	0.73	3.10	1.04	3.55	4.55
Interest Coverage	8.53	55.42	8.10	16.13	55.67

	Jubilant Ingrevia	Garware Hi-Tech	Rossari Biotech	Chemcon Speciality	Chembond Chemical
Debtors to sales (%)	17.83	2.50	23.26	26.48	35.06
Asset Turnover	0.84	0.75	0.99	0.43	1.40
Receivable days	57.72	8.14	78.24	87.67	120.15
Inventory Days	75.74	59.80	57.59	116.64	23.34
Payable days	139.62	62.71	66.69	40.07	70.27
Cash Conversion Cycle	-6.16	5.23	69.14	164.24	73.22

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.